Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome

Annals of the American Thoracic Society

Volumn 12, Issue , 2015, Pages S58-S63

  Rubenfeld, Gordon D ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

ARDS; Clinical trials; Statistical power; Study methodology

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DRUG TREATMENT FAILURE; FRUSTRATION; HUMAN; NOISE REDUCTION; NONHUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; METHODOLOGY; RESPIRATORY DISTRESS SYNDROME, ADULT;

CLINICAL TRIALS AS TOPIC; HUMANS; RESEARCH DESIGN; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84928741720     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201409-414MG     Document Type: Conference Paper

References (45)

1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
2. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, Slutsky AS, Pullenayegum E, Zhou Q, Cook D, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010;303:865-873.
3. Sud S, Friedrich JO, Adhikari NKJ, Taccone P, Mancebo J, Polli F, Latini R, Pesenti A, Curley MAQ, Fernandez R, et al. Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ 2014;186:E381-E390.
4. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354:2564-2575.
5. Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal J-M, Perez D, Seghboyan J-M, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-1116.
6. Duggal A, Ganapathy A, Mohana Ratnapalan M, Adhikari NK. Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiol (In press)
7. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-165.
8. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-1684.
9. Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005;294:218-228.
10. Ioannidis JPA. Why most published research findings are false. PLoS Med 2005;2:e124.
11. Sackett DL. Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ 2001;165:1226-1237.
12. Browner WS, Newman TB. Are all significant P values created equal?The analogy between diagnostic tests and clinical research. JAMA 1987;257:2459-2463.
13. Scales DC, Rubenfeld GD. Estimating sample size in critical care clinical trials. J Crit Care 2005;20:6-11.
14. Goodman SN. Toward evidence-based medical statistics. 1: the P value fallacy. Ann Intern Med 1999;130:995-1004.
15. Goodman SN. Toward evidence-based medical statistics. 2: the Bayes factor. Ann Intern Med 1999;130:1005-1013.
16. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, Malacrida R, Di Giulio P, Fumagalli R, Pelosi P, et al.; Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001;345:568-573.
17. Lauer MS, D'Agostino RB Sr. The randomized registry trial: the next disruptive technology in clinical research? N Engl J Med 2013;369:1579-1581.
18. Truog RD, Robinson W, Randolph A, Morris A. Is informed consent always necessary for randomized, controlled trials? N Engl J Med 1999;340:804-807.
19. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and statistics in medicine. Stat Med 2007;26:2-19.
20. Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, Taljaard M. Ottawa Ethics of Cluster Randomized Trials Consensus Group. The Ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Med 2012;9:e1001346.
21. Reade MC, Delaney A, Bailey MJ, Harrison DA, Yealy DM, Jones PG, Rowan KM, Bellomo R, Angus DC. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 2010;36:11-21.
22. Rubenfeld GD. How much PEEP in acute lung injury. JAMA 2010;303:883-884.
23. Clinical Centers for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network. May 15, 2013 [accessed 2014 August 20]. Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-014.html.
24. Rubenfeld GD, Abraham E. When is a negative phase II trial truly negative? Am J Respir Crit Care Med 2008;178:554-555.
25. Chevret S. Bayesian adaptive clinical trials: a dream for statisticians only? Stat Med 2012;31:1002-1013.
26. Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). Guidance for industry adaptive design clinical trials for drugs and biologics. 2010. [accessed 2014 Sept 4]. Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm201790.pdf.
27. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985;76:479-487.
28. Schönbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004;109(21, Suppl 1):II18-II26.
29. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
30. Agarwal R, Srinivas R, Nath A, Jindal SK. Is the mortality higher in the pulmonary vs the extrapulmonary ARDS? A meta analysis. Chest 2008;133:1463-1473.
31. Spragg RG, Lewis JF, Walmrath H-D, Johannigman J, Bellingan G, Laterre P-F, Witte MC, Richards GA, Rippin G, Rathgeb F, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-892.
32. Spragg RG, Taut FJH, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Günther A. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 2011;183:1055-1061.
33. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995;122:17-23.
34. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996;125:605-613.
35. Rubenfeld GD. Surrogate measures of patient-centered outcomes in critical care. In: Angus DC, Carlet J, editors. Surviving intensive care. Berlin: Springer-Verlag; 2002. pp. 169-180.
36. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-61.
37. Blackwood B, Clarke M, McAuley DF, McGuigan PJ, Marshall JC, Rose L. How outcomes are defined in clinical trials of mechanically ventilated adults and children. Am J Respir Crit Care Med 2014;189:886-893.
38. Carson SS, Goss CH, Patel SR, Anzueto A, Au DH, Elborn S, Gerald JK, Gerald LB, Kahn JM, Malhotra A, et al.; American Thoracic Society Comparative Effectiveness Research Working Group. An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med 2013;188:1253-1261.
39. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38:1573-1582.
40. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092.
41. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-1056.
42. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037.
43. EMEA Committee for Medicinal Products for Human Use. Guideline on adjustment for baseline covariates. 2013. [accessed 2014 Sept 4]. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2013/06/WC500144946.pdf.
44. Esteban A, Alía I, Gordo F, de Pablo R, Suarez J, González G, Blanco J; For the Spanish Lung Failure Collaborative Group. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. Chest 2000;117:1690-1696.
45. Annane D, Sé bille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871.